会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 10. 发明授权
    • LHRH-antagonists in the treatment of fertility disorders
    • LHRH拮抗剂治疗生育障碍
    • US07393834B2
    • 2008-07-01
    • US10661780
    • 2003-09-15
    • Philippe BouchardRene FrydmanPaul DevroeyKlaus DiedrichJurgen Engel
    • Philippe BouchardRene FrydmanPaul DevroeyKlaus DiedrichJurgen Engel
    • A61K38/09A61K31/551A61K31/4743
    • A61K38/09C12M21/06
    • A method of treating infertility disorders by 1) administering an LH-RH antagonist, preferably Cetrorelix, in amounts to selectively suppress endogenous LH but not FSH secretion and 2) inducing follicle growth by administration of exogenous gonadotropin. The selective suppression OF LH allows FSH secretion to be at natural levelS thereby not affecting individual estrogen development. The LH-RH antagonist can be given as a single or dual subcutaneous dose in the range of 1 mg to 10 mg, preferably 2 mg-6 mg. In multiple dosing-posology, LH-RH antagonist can be administered subcutaneously in an amount in the range of 0.1 to 0.5 mg of LH-RH antagonist/day. LH-RH antagonist is applied starting cycle day 1 to 10, preferably on day 4 to 8, and ovulation can be induced between day 9 and 20 of the menstruation cycle by administering rec. LH, native LH-RH, LH-RH agonist or by HCG. In addition rec. LH, native LH-RH or LH-RH agonist can be given to avoid hyperstimulation syndrome and native LH-RH or a LH-RH agonist can be administered to avoid luteal phase stimulation by neutralizing the negative effects of HCG.
    • 一种通过以下方式治疗不育症:1)以选择性抑制内源性LH而不是FSH分泌的量施用LH-RH拮抗剂,优选Cetrorelix; 2)通过施用外源性促性腺激素诱导卵泡生长。 选择性抑制LH允许FSH分泌处于自然水平,从而不影响个体雌激素的发育。 LH-RH拮抗剂可以以1mg至10mg,优选2mg-6mg范围内的单次或双次皮下给药。 在多剂量剂量学中,LH-RH拮抗剂可以以0.1-0.5mg LH-RH拮抗剂/天的量皮下施用。 LH-RH拮抗剂在第1至10天开始循环,优选在第4至8天施用,并且可以在月经周期的第9至20天之间通过施用rec来诱导排卵。 LH,天然LH-RH,LH-RH激动剂或HCG。 另外rec。 可以给予LH,天然LH-RH或LH-RH激动剂以避免过度刺激综合征,并且可以施用天然LH-RH或LH-RH激动剂,以通过中和HCG的负面作用来避免黄体期刺激。